Table 1

Affinities of NPY, PP and NPY analogs for the cloned human NPY Y1, Y2, Y4, and Y5 receptor subtypes.

PeptideKi
Y1Y2Y4Y5
nM
NPY0.28  ± 0.061.2  ± 0.3N.D.1.5  ± 0.1
PPN.D.N.D.0.07  ± 0.03N.D.
1[d-Arg25]-NPY0.9  ± 0.211.6  ± 2.974.6  ± 21.343.4  ± 4.2
2[d-His26]-NPY2.0  ± 0.329.0  ± 4.720.1  ± 1.934.6  ± 3.8
3[d-Arg25,d-His26]-NPY9.7  ± 0.6399  ± 35.5852  ± 1143003  ± 440
4Des-AA10-17 [Cys7,21, Pro34]-NPY0.2  ± 0.0537.0  ± 12.45.0  ± 1.822.6  ± 5.0
5 Des-AA11-18 [Cys7,21,d-Lys9 (Ac)]-NPY0.7  ± 0.11.4  ± 0.153.5  ± 7.977.1  ± 36.1
6Des-AA11-18 [Cys7,21, d-Lys9 (Ac), Pro34]-NPY0.2  ± 0.01124  ± 11.37.3  ± 1.155.9  ± 7.4
7 Des-AA11-18[Cys7,21, d-Lys9 (Ac),d-His26]-NPY2.2  ± 0.31.4  ± 0.3206  ± 16.83023  ± 164
8Des-AA11-18 [Cys7,21, d-Lys9 (Ac),d-His26, Pro34]-NPY1.2  ± 0.1801  ± 41.431.4  ± 1.32363  ± 142

Competition binding assays were performed using membranes prepared from CHO-K1 cells expressing one of the human NPY receptor subtypes. Binding assays were performed in duplicate. Each value is the mean ± S.E.M. of three to four determinations.

  • N.D., not determined.